Embarking on an Exciting Two-Part Adventure: A Journey Unfolds!
Pablo Emilio Rodriguez Sanchez, a 58-year-old resident of Bogotá, Colombia, has embarked on a challenging journey since his diagnosis with pancreatic neuroendocrine cancer in 2019. His story highlights the importance of early detection, the emotional toll of cancer, and the ongoing fight against this rare disease.
The Start of a Life-Changing Journey
In September 2019, Pablo experienced an unexpected weight loss, prompting his doctor to recommend an abdominal ultrasound. The results revealed a mass near his pancreas, leading to further tests that confirmed a cancerous tumor. This shocking diagnosis set off a whirlwind of medical interventions.
Pablo sought immediate care at the Fundación Santa Fe de Bogotá, where he underwent a PET scan to determine the tumor’s exact location and check for metastasis. Fortunately, it was diagnosed as a stage II pancreatic neuroendocrine tumor, located in the tail of his pancreas, with no spread to other organs.
Surgical Intervention
On November 7, 2019, Pablo underwent a successful six-hour surgery to remove the tumor, conducted by Dr. Diego Triviño and his dedicated medical team. Post-surgery, he faced challenges in managing his blood sugar levels, requiring metformin to prevent diabetes. Thankfully, with a balanced diet and regular exercise, he was able to discontinue the medication after a few months.
Regular Monitoring and Hope
Pablo maintained a rigorous follow-up schedule, seeing both Dr. Triviño and his endocrinologist, Dr. César Gutiérrez, every six months. During these check-ups, he underwent blood tests and MRIs, which provided reassurance that he remained cancer-free until January 2023.
A Setback: Tumor Recurrence
In early February 2023, a new PET scan revealed the heartbreaking news: multiple lesions had appeared in the liver, indicating metastasis. This devastating diagnosis reintroduced a wave of shock for Pablo and his family. He quickly reached out to his medical team, who promptly referred him to specialists in oncology.
Pablo met with Dr. Deyanira González and Dr. Henry Vargas, both experts in neuroendocrine tumors. They explained that while a cure was not possible, treatment options were available, including monthly injections of lanreotide. This targeted therapy aims to manage tumor growth rather than eradicate it completely.
Living with Treatment
Pablo received his first lanreotide injection on March 17, 2023. Although he initially experienced mild side effects such as nausea and increased urination, he remained hopeful. Since then, he has had four doses of the medication, with noticeable side effects like weight loss and fluctuating blood sugar levels. His endocrinologist has adjusted his diabetes treatment accordingly, swapping metformin for Xigduo XR to enhance blood sugar management.
Emotional Resilience and Support
The emotional support from family has been invaluable during this difficult time. To further bolster his mental health, Pablo sought help from psychologist Dr. Liliana Cruz, who specializes in integrative transpersonal therapy. This therapy has equipped him with tools to navigate the emotional landscape of living with cancer, helping him maintain a positive outlook despite the challenges.
Pablo is determined to document his journey and share his experiences with others facing similar battles. He believes that by sharing his story, he can inspire hope and resilience in those who may find themselves in the same situation.
A Message of Hope
Pablo’s journey underscores the significance of early detection, ongoing treatment, and emotional support in battling cancer. He remains optimistic about the future, looking forward to sharing updates on his progress and continuing to advocate for awareness about neuroendocrine tumors.
Thank you for following Pablo’s inspiring story—may it serve as a beacon of hope for many.
